Home » Topics » Regulatory » Patents

Patents
RSS

Sun Pharma Advanced Research discovers novel Bruton tyrosine kinase inhibitors

Aug. 23, 2017

Jiangsu Chia Tai Tianqing, Centaurus BioPharma and Lianyungang Ruzhong present new BET inhibitors

Aug. 22, 2017

Novel 5-HT-2 receptor antagonists patented by Shenzhen Targetrx Biotechnology

Aug. 22, 2017

Chiesi discovers new phosphatidylinositol 3-kinase inhibitors

Aug. 22, 2017

Shanghai Fochon Pharmaceutical, Fochon Pharma patent CDK4 and CDK6 inhibitors

Aug. 21, 2017

Novel excitatory amino acid transporter 3 inhibitors discovered at Roche

Aug. 21, 2017

Toray Industries divulges novel nuclear receptor ROR-gamma antagonists

Aug. 21, 2017

Medshine Discovery, Jiangsu Chia Tai Tianqing Pharmaceutical patent bile acid receptor agonists

Aug. 18, 2017

Beijing Marino Biotechnology presents new CAR-T cells expressing non-functional EGFR

Aug. 17, 2017

Fate Therapeutics describes novel immune cell modulation compositions

Aug. 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...